Approved Formulary
Add Formweb to your mobile device
Approved Formulary
Black Box Warning: Increased CV and Endometrial Cancer Risk
Search results for:
ESTRADIOL
ESTRADIOL
| Drug Name | Form | Strength | Non-Formulary | Notes |
|---|---|---|---|---|
| DELESTROGEN | INJECTION | valerate 40 mg/ml | ||
| DELESTROGEN | INJECTION | Valerate 10 mg/ml | ||
| DELESTROGEN | INJECTION | valerate 20 mg/ml | ||
| DEPO-ESTRADIOL | INJECTION | cypionate 5 mg/ml | ||
| ESTRACE | TABLET | 0.5 mg | ||
| GYNODIOL | TABLET | 0.5 MG | ||
| ESTRACE | TABLET | 1 mg | ||
| GYNODIOL | TABLET | 1 MG | ||
| GYNODIOL | TABLET | 1.5 MG | ||
| ESTRACE | TABLET | 2 mg | ||
| GYNODIOL | TABLET | 2 MG | ||
| MENOSTAR | TRANSDERMAL PATCH | 0.014 MG/24 HOURS (ONCE WEEKLY) | ||
| ALORA | TRANSDERMAL PATCH | 0.025 MG/24 HOURS (TWICE WEEKLY) | ||
| ESCLIM | TRANSDERMAL PATCH | 0.0375 MG/24 hours (TWICE WEEKLY) | ||
| VIVELLE | TRANSDERMAL PATCH | 0.0375 MG/24 HOURS (TWICE WEEKLY) | ||
| ALORA | TRANSDERMAL PATCH | 0.05 MG/24 HOURS (TWICE WEEKLY) | ||
| ESTRADERM | TRANSDERMAL PATCH | 0.05 mg/24 hours twice weekly | ||
| VIVELLE | TRANSDERMAL PATCH | 0.05 MG/24 HOURS (TWICE WEEKLY) | ||
| ALORA | TRANSDERMAL PATCH | 0.075 MG/24 HOURS (TWICE WEEKLY) | ||
| ALORA | TRANSDERMAL PATCH | 0.1 MG/24 HOURS (TWICE WEEKLY) | ||
| CLIMARA | TRANSDERMAL PATCH | 0.1 MG/24 HOURS (WEEKLY) | ||
| ESTRADERM | TRANSDERMAL PATCH | 0.1 mg/24 hours twice weekly | ||
| VIVELLE | TRANSDERMAL PATCH | 0.1 MG/24 HOURS (TWICE WEEKLY) | ||
| ESTRACE | VAGINAL CREAM | 0.1 MG/GM | ||
| ESTRING | VAGINAL RING | 2 MG | ||
| VAGIFEM | VAGINAL TAB/SUPPOSITORY | 25 MCG |
Last updated: Aug. 16, 2017
- Black Box Warning: Increased CV and Endometrial Cancer Risk
WEEKLY PATCH = CLIMARA, MENOSTAR; TWICE-WEEKLY PATCHES = ALORA, ESCLIM, ESTRADERM, VIVELLE, VIVELLE-DOT. Do not cut patches.